Introduction {#sec1-1}
============

Stress is known as a state of psychological response to actual or potential stressors that tend to disturb the homeostasis of the body, especially the brain functions.\[[@ref1]\] Stress alters the activity of the hypothalamic-pituitary-adrenal (HPA) axis and affects the secretion of glucocorticoids such as corticosterone (CORT) in rodents.\[[@ref2]\] Previous study has shown alterations due to chronic stress in many factors including levels of hormones as well as many biochemical and neurochemical substances in both the serum and the brain.\[[@ref1][@ref2][@ref3]\] Hence, stress can impair biological, behavioral, and electrophysiological activities in subjects.\[[@ref4][@ref5][@ref6]\] Moreover, memory processes can be impaired by changes in the functions of the hippocampus and probably the frontal cortex under stressful conditions.\[[@ref7][@ref8][@ref9]\] These structures are the most important regions involved in memory, moods, cognition, and neuroendocrine stress reactivity.\[[@ref7][@ref10][@ref11][@ref12]\]

As an immediate remedial strategy, plant drugs have been proposed to enhance brain functions and public attention has been increasingly drawn to herbal medication as supplementary medicines due to their availability and supposedly lower side effects.\[[@ref1]\]

Cultivated in many parts of the world, *Crocus sativus L.* (saffron) is especially grown in Iran, Italy, Greece, Spain, and China.\[[@ref13]\] One of the most important active components of saffron is crocin (carotenoid pigment), which is responsible for its characteristic color\[[@ref14]\] and is a glucosyl ester of crocetin and water-soluble carotenoids.\[[@ref15]\] Crocin as an anti-oxidant has various pharmaceutical advantages such protection against oxidative stress\[[@ref16][@ref17][@ref18][@ref19]\] and improvement of memory deficits.\[[@ref13][@ref20]\] It is seam that daily consumption of saffron can be useful for ameliorating the destructive effects of stress. Hypothesizing that different doses of crocin might induce changes in chronic emotional stress, we designed and conducted this study to explore the effects of different doses of crocin on learning, memory, and both hippocampal and frontal cortical CORT levels to verify the protection it might offer against memory deficit in rats subjected to chronic restraint stress.

Materials and Methods {#sec1-2}
=====================

Experimental animals {#sec2-1}
--------------------

Forty male Wistar rats with initial weights of 250-300 g were obtained from Pasteur Institute, Tehran, Iran. All the experimental protocols were approved by the Committee of Ethics of Isfahan University of Medical Sciences (Isfahan, Iran) and implemented in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80--23, revised in 1996). The rats were housed under controlled humidity (50% ± 5%) and light conditions (12 h light/dark cycle; lights on 07:00 am to 19:00 pm). Room temperature was set to 23 ± 2°C and food and water were made available *ad libitum*, except during stress sessions. Cage size and colony grouping were completely similar across the groups. All the behavioral experiments were carried out at 15:00-16:00 pm. A 2-week period was allowed for adaptation before the animals were randomly divided into the following five groups (*n* = 8 in each):

Control group (Co): Rats were maintained in the laboratory room receiving no special treatmentSham group (Sh): Rats received equal volumes of saline (drug solvent) for 21 daysRestraint stress group (St.R): Rats were under restraint stress for 6 h/day over the 21-day experimental periodRestraint stress-crocin 30 group (St.R-C30): Rats were under restraint stress for 6 h/day over the 21-day experimental period and received daily injection of 30 mg/kg crocinRestraint stress-crocin 60 group (St.R-C60): Rats received the same treatment as the St.R-C30 group except that their daily injections contained 60 mg/kg of crocin.

Experimental procedures {#sec2-2}
-----------------------

### Drugs {#sec3-1}

Depending on their experimental group, the stressed rats received intraperitoneal (i.p) injections of saline-dissolved 30 or 60 mg/kg of crocin (Sigma-Aldrich Co. USA) for 21 days.

### Stress Paradigms {#sec3-2}

In the chronic stress model, the rats would be placed in tightly fit restrainers for 6 h/day over the whole 21 days\[[@ref7][@ref21]\] of the experiment. Hence, restraint was a powerful emotional stress.\[[@ref22]\] The restraint stress was induced throughout the experimental period from 8:00 am to 14:00 pm each day.\[[@ref21][@ref23]\]

### Behavioral Paradigms {#sec3-3}

The passive avoidance test, which is a hippocampus-dependent memory task involving the cognitive memory,\[[@ref2][@ref24][@ref25]\] was used in this study with the passive avoidance apparatus (Shuttle box 64 cm × 25 cm × 35 cm) divided into two rooms of identical size (32 cm × 25 cm × 35 cm) with sliding guillotine doors and grid floors. On day 19 of the experiment, each rat was placed in the apparatus for 300 s for habituation. On the following day (day 20), a single learning trial was performed. On day 21, the memory trial of the passive avoidance test was evaluated. Both habituation and memory trial were accomplished without any foot shocks. In the learning trial, the rats were placed individually in the light room for 60 s before the guillotine door was raised. When the rat entered the dark room, the door would be closed and a single electrical shock (0.5 mA, 2 s; once) would be delivered to the animal\'s foot through the grid floor using an isolated stimulator.\[[@ref26]\] The initial latency (IL) of entrance into the dark room was recorded before inducing the electrical shock. In the memory trial, the step-through latency (STL), defined as the delay of entrance into the dark room from the light room (up to a maximum of 300 s), was measured. Finally, the difference between the initial and the step-through latencies was interpreted as the occurrence of learning in the animal experimental research.\[[@ref27]\]

### Assessment of corticosterone levels in the hippocampus and frontal cortex {#sec3-4}

At the end of the experiments, the animals were anesthetized with an i.p injection of urethane (1.5 g/kg, Sigma-Aldrich Co., USA) and sacrificed at 16:00--18:00 by decapitation on day 22. Following decapitation, the brain of each animal was immediately removed from the skull and the hemi-hippocampus and hemi-frontal cortex were instantly dissected to be kept on dry ice, which were subsequently immersed in Problock™-50, EDTA-free (Gold Bio Co., USA) and in a phosphate buffer solution (PBS buffer, 0.01 M, pH 7.4), separately. Indeed, this solution contained a complete protease inhibitor cocktail.\[[@ref28]\] The hippocampus and frontal cortex were homogenized and centrifuged in a cooled centrifuge (4°C, 10,000 g) for 20 min. The supernatant was collected and stored at − 80°C until assessment. The commercial Enzyme-Linked Immuno Sorbent Assay (ELISA) kit (Zellbio Co., Marburg, Germany) was used to assess the CORT levels in the hippocampus and frontal cortex. The amount of CORT was determined in a given volume of the supernatant.\[[@ref2][@ref28][@ref29]\]

Statistical analysis {#sec2-3}
--------------------

The IL and STL of the passive avoidance test, CORT levels, body weight, and daily BWDs were analyzed by ANOVA followed by Tukey\'s *post hoc* test for multiple groups. Comparisons of IL and STL (within groups) were analyzed using the paired sample *t*-test. Furthermore, body weight trends were compared using repeated measures ANOVA followed by Tukey\'s *post hoc* test. Pearson\'s correlation analysis was performed to find the correlation between and among the variables. All the data were reported as means ± standard error of mean. The value of *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

Not all the data showed significant differences between the control (Co) and the sham (Sh), indicating that the injection had no significant effects on these parameters.

Step-through latency {#sec2-4}
--------------------

Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}, respectively, show the initial and the stepthrough (IL and STL, respectively) latency results in the passive avoidance test after 1 day for all the groups. Based on the one-way ANOVA, no significant differences were observed in IL values across the groups \[[Figure 1](#F1){ref-type="fig"}\].

![Initial latency to enter the dark room of the passive avoidance apparatus for all the groups before receiving a foot shock (*n* = 8). Results are expressed as means ± standard error of mean (one-way of ANOVA followed by Tukey\'s *post hoc* test). No significant differences were observed among the groups. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g001){#F1}

![Step-through latency to enter the dark room of the passive avoidance apparatus for all the groups 1 day after receiving the foot shock (*n* = 8). Results are expressed as means ± standard error of mean (one-way of ANOVA followed by Tukey\'s *post hoc* test). \*\**P* \< 0.01 compared to the control, ^\#\#^*P* \< 0.01 compared to the Sham, ^θ^*P* \< 0.05 and ^θθ^*P* \< 0.01 compared to the Stress group. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g002){#F2}

In the stress (St.R) group, the STL values were significantly (*P* \< 0.01) lower than those recorded for the control and sham groups, indicating the reduced passive avoidance memory as a result of the restraint stress \[[Figure 2](#F2){ref-type="fig"}\].

As shown in [Figure 2](#F2){ref-type="fig"}, the values for STL showed significant enhancements (*P* \< 0.01 and *P* \< 0.05, respectively) in the stress-crocin 30 (St.R-C30) and stress-crocin 60 (St.R-C60) groups when compared with the St.R group, indicating that although chronic crocin treatment was able to produce a significant increase in memory after 1 day, daily administration of 30 mg/kg of crocin had more beneficial effects than did the 60 mg/kg dose on cognitive memory in the emotional stress model.

The results of initial and stepthrough latencies (IL and STL, respectively) were analyzed using the paired sample *t*-test to evaluate within group latency changes. As shown in [Figure 3](#F3){ref-type="fig"}, significant differences were detected between IL and STL in all the groups, except between all the groups and the St.R one (*P* \< 0.001 in Co and Sh groups, *P* \< 0.01 in St.R-C30, and *P* \< 0.05 in St.R-C60 groups).

![Initial latency and step-through latency after 1 day to enter the dark room of the passive avoidance apparatus before and after the foot shock (within groups) (*n* = 8). Results are expressed as means ± standard error of mean (paired sample *t*-test). ^+^*P* \< 0.05, ^++^*P* \< 0.01 and ^+++^*P* \< 0.001 initial latency relative to the step-through latency. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g003){#F3}

Assessment of corticosterone levels in the hippocampus and frontal cortex {#sec2-5}
-------------------------------------------------------------------------

As shown in Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}, significant enhancements (*P* \< 0.05) were observed in the hippocampal and frontal cortical CORT levels in the St.R group when compared with the control \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\]. CORT levels decreased in the St.R C30 and St.R C60 groups relative to those in the St.R group. However, the decline was significant only in the St.R-C30 group rather than in the St.R \[Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}\].

![Effects of chronic restraint stress and different doses of crocin on hippocampal corticosterone levels (ng/ml) in the different groups (*n* = 8). Results are expressed as mean ± standard error of mean (ANOVA test Tukey\'s *post hoc* test). \**P* \< 0.05 compared to the control, ^θ^*P* \< 0.05 compares to the Stress group. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g004){#F4}

![Effects of chronic restraint stress and different doses of crocin on the frontal cortex corticosterone levels (ng/ml) in the different groups (*n* = 8). Results are expressed as mean ± standard error of mean (ANOVA test Tukey\'s *post hoc* test). \**P* \< 0.05 compared to the control, ^θ^*P* \< 0.05 compared to the Stress group. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g005){#F5}

Correlation between hippocampal and frontal cortical corticosterone levels {#sec2-6}
--------------------------------------------------------------------------

A positive correlation was established between the hippocampus and the frontal cortex with respect to their CORT levels across the groups (\[*P* \< 0.01 in St.R-C30 and *P* \< 0.05 in others\]; Pearson\'s correlations; *r* = 0.895 in Co, *r* = 0.883 in St.R, *r* = 0.967 in St.R-C30, and *r* = 0.880 in St.R-C60) \[[Figure 6](#F6){ref-type="fig"}\]. These findings revealed a direct relationship between the CORT levels in the hippocampus and the frontal cortex.

![Correlation analysis of the frontal cortex and hippocampal corticosterone levels in the different groups (*n* = 8). Results are expressed as means ± standard error of mean (Pearson\'s correlation *t*-test). A significant (*P* \< 0.05) and positive correlation was established between the frontal cortex corticosterone levels and those of the hippocampus in all the groups examined. Co: Control group, Sh: Sham group, St.R: Restrain stress group, St.R-C30: Restrain stress-Crocin 30 group, St.R-C60: Restrain stress-Crocin 60 group](ABR-6-157-g006){#F6}

Discussion {#sec1-4}
==========

The effects of different doses (30 and 60 mg/kg) of crocin were investigated on learning, memory, and the hippocampal and frontal cortical CORT levels in rats subjected to chronic restraint stress as a chronic emotional stress model.

The findings confirm the hypothesis that chronic stress is accompanied by a disturbance in STL as memory. It has been shown that chronic restraint stress impairs brain functions and memory processing in rats,\[[@ref2][@ref30][@ref31][@ref32][@ref33]\] whereas it also alters such neuronal properties as suppression of neurogenesis in the dentate gyrus of the hippocampus\[[@ref34][@ref35][@ref36]\] and changes the emotional and stress-related responses in animals.\[[@ref2][@ref30]\] Various mechanisms are involved in the stress responses; these include changes in stress biomarkers, hormones, and neurotransmitters as well as free radical generation and anti-oxidant enzyme activities.\[[@ref2][@ref37][@ref38]\] In contrast to the present results, one study reported on the habituation of animals to chronic stress conditions.\[[@ref36]\] The discrepancy observed between the two results may be attributed to differences in the types and durations of stress induced and/or types of task behavior designed.\[[@ref31]\]

Another aspect of the present study involved crocin dosage which revealed that daily administration of crocin (30 and 60 mg/kg) led to beneficial effects on learning in stressed rats. Moreover, crocin improved the memory deficit induced by stress although a 30 mg/kg dose was found to be more effective than the 60 mg/kg one on the cognitive memory deficit as measured by the passive avoidance test under restraint stress conditions (as an emotional stress model) \[Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}\]. Using the Morris water maze task, Ghadrdoost *et al*. observed that crocin prevented spatial memory impairment induced by chronic stress.\[[@ref39]\] In agreement with this finding, previous studies had also shown that administration of crocin (30 mg/kg) led to a significantly reduced memory deficit induced by scopolamine.\[[@ref13][@ref39]\] In general, it seems that crocin has beneficial effects on different kinds of memory and that the harmful effects of chronic stress on brain functions can be prevented or remedied by crocin. In contrast to the results of the current results, low doses (15 and 30 mg/kg) of crocin were reported to have no influence on animal behavior.\[[@ref13]\] Based on these observations, it might be claimed that lower doses of crocin probably reverse memory impairment through a variety of mechanisms involving different biochemical factors.\[[@ref40][@ref41]\] In addition, it is important to note that the differences observed in the effects of crocin among different studies might be related to differences in the behavioral tasks used in different experimental protocols.\[[@ref42]\]

Chronic stress in the current study was observed to give rise to a significant increase in the hippocampal and frontal cortical CORT levels. Furthermore, the hippocampus and frontal cortex were found to be positively correlated with respect to their CORT levels. It has been demonstrated that stress disrupts brain cognitive functions by causing impairments in the prefrontal cortex.\[[@ref43]\] In the light of what went above, this can now be attributed to changes in CORT levels. In addition, previous studies have shown that enhanced CORT levels might have implications for post-stress brain plasticity and behavioral changes in rat\'s brain and hippocampus.\[[@ref2][@ref7]\] Other studies demonstrated that the aqueous extract of saffron gave rise to increased release of such important neurotransmitters as dopamine and glutamate in rats' brains, as a result of which depression symptoms reduced. Crocin has also been shown to inhibit N-methyl-D-aspartate (NMDA) glutamate receptors and sigma opioid receptors isolated from rat spinal cord.\[[@ref44]\]

Our current findings revealed no significant correlations in the stressed groups between their memory functions and their CORT levels in the hippocampus, frontal cortex, or both. It may, therefore, be suggested that a wide variety of mechanisms and multiple factors such as changes in neurotransmitters' release, neurotrophic factors, leptin, and oxidative stress affecting CORT level might be involved in induced memory deficit as a result of stress.\[[@ref45][@ref46][@ref47]\]

Administration of crocin decreased CORT levels in both the hippocampus and the frontal cortex of stressed rats although the effects were significant only in the St.R-C30 group. Compared to the high dose of 60 mg/kg, the low crocin dose of 30 mg/kg administered in the present study led to improved CORT levels. This is somehow in agreement with Ghadrdoost and *et al*. who reported more beneficial effects of a crocin dose of 30 mg/kg than one of 15 mg/kg of crocin.\[[@ref39]\] It, therefore, seems that the golden crocin dose of 30 mg/kg, no less and no more, may not only play a crucial role in the development and maintenance of memory but also decrease CORT levels in the hippocampus and frontal cortex in emotionally stressed subjects. Another conclusion to be drawn is that the beneficial effects of crocin are dose-dependent. Finally, a study has suggested that crocin might have free radical scavenging and antioxidant activities.\[[@ref48]\] If so, it seems that crocin protects the hippocampus and the frontal cortex against the oxidative damage of chronic stress.

Based on the above observations, the central mechanisms such as interactions with the HPA axis and other brain areas or the involvement of peripheral structures might be similar to other memory mechanisms.\[[@ref14]\] However, the hippocampus and the fontal cortex are more similar in their functions such as regulation of the HPA axis.\[[@ref10][@ref49]\] and expression of glucocorticoid receptors.\[[@ref10][@ref50]\] Some scholars have, however, shown that the hippocampus contains higher densities of the glucocorticoid receptors than does the prefrontal cortex.\[[@ref10]\] It, thus, be concluded that the former is more responsive to corticosteroids than the latter is.\[[@ref51]\]

Conclusions {#sec1-5}
===========

The low dose (30 mg/kg of crocin) was found capable of reversing the harmful effects of chronic restraint stress on memory and also able to lower the CORT levels in both the hippocampus and the frontal cortex. Based on the results obtained from the present and previous studies, it may be suggested that the potential effects of crocin on emotional chronic stress are dose-dependent. Further research is, however, required to shed more light on the possible mechanism(s) involved. Investigation of receptor regulation, assessment of other hormones, and identification of biochemical factors through which crocin might affect brain functions might be suggested for future study. In addition, the molecular pathway of glucocorticoid receptors in response to crocin may be a more appropriate topic of research to determine the mechanism through which crocin affects learning and memory in animals under stress.
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